Avenue Therapeutics, Inc. (ATXI)

Avenue Therapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Total Valuation

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Nov 4, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Market Capitalization	1	2	4	2	6	19
Market Cap Growth	-51.92%	-47.28%	92.60%	-61.53%	-70.79%	-80.95%
Enterprise Value	-1	-3	1	1	5	18
Last Close Price	0.43	0.68	2.00	12.08	87.00	1021.50

Price Ratios

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Nov 4, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
PS Ratio	-	1.54	-	-	-	-
PB Ratio	2.48	1.18	2.21	3.26	1.70	5.50
P/TBV Ratio	2.48	1.18	1.47	1.35	1.42	5.50

Financial Efficiency

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Nov 4, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Net Debt / Equity Ratio	-3.41	-1.56	-1.40	-2.73	-2.05	-1.09
Asset Turnover	-	0.50	-	-	-	-
Quick Ratio	1.38	2.60	3.18	1.49	1.87	7.57
Current Ratio	1.40	2.67	3.28	1.55	1.91	7.78
Return on Equity (ROE)	-164.83%	-159.82%	-931.95%	-535.10%	-107.28%	-128.43%
Return on Assets (ROA)	-63.14%	-73.31%	-311.89%	-209.03%	-93.05%	-64.85%
Return on Capital Employed (ROCE)	-544.80%	-179.40%	-607.90%	-2223.20%	-246.30%	-108.30%

Yields

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Nov 4, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Earnings Yield	-199.87%	-134.34%	-283.65%	-486.53%	-64.07%	-19.66%
Buyback Yield / Dilution	-34.27%	-141.75%	-817.14%	-384.72%	-92.83%	-2.98%

Data Source: S&P Global Market Intelligence Last updated: Aug 7, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Nov 6, 2026

Data Sources Report a data error